Evidence map›Paper›PMID 31363086›Full record

ArticleNature communications2019

Modification of messenger RNA by 2'-O-methylation regulates gene expression in vivo.

Brittany A Elliott, Hsiang-Ting Ho, Srivathsan V Ranganathan, Sweta Vangaveti, Olga Ilkayeva, Hala Abou Assi, Alex K Choi, Paul F Agris, Christopher L Holley

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 209 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Regulation of RNA-binding proteins by small biomolecules.Nature reviews. Molecular cell biology · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. RNA modification systems as therapeutic targets.Nature reviews. Drug discovery · 2026
    Review
  15. PXDN regulated by WTAP/YTHDF1-mediated mJournal of experimental & clinical cancer research : CR · 2025
    Article
  16. Genome-wide profiling of RNA 2'-bioRxiv : the preprint server for biology · 2025
    Article
  17. snoCLASH Reveals Extensive snoRNA-mRNA Interaction Networks.bioRxiv : the preprint server for biology · 2025
    Article
  18. Article
  19. Review
  20. Review

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Brittany A ElliottDepartment of Medicine, Duke University Medical Center, Durham, NC, 27705, USA.ORCID http://orcid.org/0000-0001-5907-1231
Hsiang-Ting HoDepartment of Medicine, Duke University Medical Center, Durham, NC, 27705, USA.
Srivathsan V RanganathanThe RNA Institute, State University of New York, Albany, NY, 12222, USA.
Sweta VangavetiThe RNA Institute, State University of New York, Albany, NY, 12222, USA.
Olga IlkayevaDuke Molecular Physiology Institute, Duke University, Durham, NC, 27701, USA.
Hala Abou AssiDepartment of Medicine, Duke University Medical Center, Durham, NC, 27705, USA.
Alex K ChoiDepartment of Medicine, Duke University Medical Center, Durham, NC, 27705, USA.
Paul F AgrisDepartment of Medicine, Duke University Medical Center, Durham, NC, 27705, USA.
Christopher L HolleyDepartment of Medicine, Duke University Medical Center, Durham, NC, 27705, USA. cholley@duke.edu.ORCID http://orcid.org/0000-0002-2870-3352
Duke Medical Center · USAlbany State University · USDuke University · US

Funding

MULTIDISCIPLINARY HEART &VASCULAR DISEASEST32HL007101 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 1985 to 2020
$9.8M
The Role of RNA Modifications in Heart FailureR01HL146381 · NHLBI · DUKE UNIVERSITY · PI HOLLEY, CHRISTOPHER LEE · 2019 to 2023
$1.8M
SnoRNA-guided modifications of mRNAR01GM135383 · NIGMS · DUKE UNIVERSITY · PI HOLLEY, CHRISTOPHER LEE · 2020 to 2023
$1.3M
SNORNAS ARE ESSENTIAL MEDIATORS OF ROS SIGNALING IN CARDIOVASCULAR CELLSK08HL114889 · NHLBI · WASHINGTON UNIVERSITY · PI HOLLEY, CHRISTOPHER LEE · 2012 to 2016
$614k
Role of snoRNAs in regulation of cardiac hypertrophyR03HL135475 · NHLBI · DUKE UNIVERSITY · PI HOLLEY, CHRISTOPHER LEE · 2016 to 2017
$159k
American Heart Association-American Stroke Association 14POST20380015American Heart Association-American Stroke Association 16POST27540007NHLBI NIH HHS K08 HL114889NHLBI NIH HHS R01 HL146381NHLBI NIH HHS R03 HL135475NHLBI NIH HHS T32 HL007101NIGMS NIH HHS R01 GM135383
6 · The paper itself

Abstract

Epitranscriptomic modifications of mRNA are important regulators of gene expression. While internal 2'-O-methylation (Nm) has been discovered on mRNA, questions remain about its origin and function in cells and organisms. Here, we show that internal Nm modification can be guided by small nucleolar RNAs (snoRNAs), and that these Nm sites can regulate mRNA and protein expression. Specifically, two box C/D snoRNAs (SNORDs) and the 2'-O-methyltransferase fibrillarin lead to Nm modification in the protein-coding region of peroxidasin (Pxdn). The presence of Nm modification increases Pxdn mRNA expression but inhibits its translation, regulating PXDN protein expression and enzyme activity both in vitro and in vivo. Our findings support a model in which snoRNA-guided Nm modifications of mRNA can regulate physiologic gene expression by altering mRNA levels and tuning protein translation.

Indexed as

Extracellular Matrix ProteinsGene Expression RegulationHumansMethylationMethyltransferasesPeroxidasePeroxidasinProtein BiosynthesisRNA, MessengerRNA, Small NucleolarExtracellular Matrix ProteinsMethyltransferasesPeroxidasePeroxidasinRNA, MessengerRNA, Small Nucleolar

Identifiers

PMID31363086
PMCPMC6667457
OpenAlexW2964973973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.